10/25/2012 10:01:50 AM
RICHMOND, Calif., Oct. 24, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported third quarter 2012 financial results and accomplishments. For the third quarter ended September 30, 2012, Sangamo reported a consolidated net loss of $5.8 million, or $0.11 per share, compared to a net loss of $9.6 million, or $0.18 per share, for the same period in 2011. As of September 30, 2012, the Company had cash, cash equivalents and marketable securities of $76.1 million.
comments powered by